MoneyWorks4Me

Medicamen Biotech informs about disclosure

18 Dec 2021 Evaluate
Medicamen Biotech has informed that it enclosed the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received by the company from Growel Remedies for sale of equity share.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..